Prions: So many fibers, so little infectivity

Trends in Biochemical Sciences

Volumn 29, Issue 4, 2004, Pages 162-165

  May, Barnaby C H ^a,b   Govaerts, Cedric ^b   Prusiner, Stanley B ^a,b   Cohen, Fred E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

DISULFIDE BOND; FIBER; IN VITRO STUDY; INFECTION; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW;

EID: 1842663089     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2004.02.008     Document Type: Short Survey

References (22)

1. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13363-13383.
2. Caughey B. Prion protein conversions: insight into mechanisms, TSE transmission barriers and strains. Br. Med. Bull. 66:2003;109-120.
3. Saborio G.P., et al. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 411:2001;810-813.
4. Adler V., et al. Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro. J. Mol. Biol. 332:2003;47-57.
5. Deleault N.R., et al. RNA molecules stimulate prion protein conversion. Nature. 425:2003;717-720.
6. Bossers A., et al. Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. J. Virol. 74:2000;1407-1414.
7. Houston F., et al. Prion diseases: BSE in sheep bred for resistance to infection. Nature. 423:2003;498.
8. Meier P., et al. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease. Cell. 113:2003;49-60.
9. Baskakov I.V., et al. Self-assembly of recombinant prion protein of 106 residues. Biochemistry. 39:2000;2792-2804.
10. Hill A.F., et al. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80:1999;11-14.
11. Lee S., Eisenberg D. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process. Nat. Struct. Biol. 10:2003;725-730.
12. Jackson G.S., et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science. 283:1999;1935-1937.
13. Swietnicki W., et al. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry. 39:2000;424-431.
14. Welker E., et al. A role for intermolecular disulfide bonds in prion diseases? Proc. Natl. Acad. Sci. U. S. A. 98:2001;4334-4336.
15. McKinley M.P., et al. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J. Virol. 65:1991;1340-1351.
16. Welker E., et al. Intramolecular versus intermolecular disulfide bonds in prion proteins. J. Biol. Chem. 277:2002;33477-33481.
17. Knaus K.J., et al. Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat. Struct. Biol. 8:2001;770-774.
18. Kocisko D.A., et al. Cell-free formation of protease-resistant prion protein. Nature. 370:1994;471-474.
19. Lucassen R., et al. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups. Biochemistry. 42:2003;4127-4135.
20. Muramoto T., et al. Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc. Natl. Acad. Sci. U. S. A. 93:1996;15457-15462.
21. Chien P., et al. Generation of prion transmission barriers by mutational control of amyloid conformations. Nature. 424:2003;948-951.
22. Zahn R., et al. NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. U. S. A. 97:2000;145-150.